Search research articles
Contact Us
Filters
Showing results (1-10 of 151) with videos related to
Page
of 16
Sort By:
Antiviral Research
|
October 31, 2002
Inhibition of host kinase activity altered by the LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease
Lori Cooper, Richard Longnecker
Virology
|
February 20, 2004
Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation
Toni Portis, Richard Longnecker
Journal of Virology
|
June 16, 2005
Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation
Makoto Fukuda, Richard Longnecker
Virology
|
May 5, 2007
Functional homology of gHs and gLs from EBV-related gamma-herpesviruses for EBV-induced membrane fusion
Jasmina Omerović, Richard Longnecker
Molecular Cancer Therapeutics
|
February 2, 2011
Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma
Osman Cen, Richard Longnecker
Journal of Virology
|
October 13, 2006
Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity
Mark Rovedo, Richard Longnecker
Virology
|
December 8, 2006
Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stability
Masato Ikeda, Richard Longnecker
Journal of Virology
|
January 30, 2004
Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway
Makoto Fukuda, Richard Longnecker
Journal of Virology
|
June 27, 2008
Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn
Mark Rovedo, Richard Longnecker
Journal of Virology
|
December 13, 2002
Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development
Toni Portis, Richard Longnecker
Page
of 16
Search research articles
Search
Showing results (1-10 of 151) with videos related to
Sort By:
Page
of 16
Antiviral Research
|
October 31, 2002
Inhibition of host kinase activity altered by the LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease
Lori Cooper, Richard Longnecker
Virology
|
February 20, 2004
Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation
Toni Portis, Richard Longnecker
Journal of Virology
|
June 16, 2005
Epstein-Barr virus (EBV) latent membrane protein 2A regulates B-cell receptor-induced apoptosis and EBV reactivation through tyrosine phosphorylation
Makoto Fukuda, Richard Longnecker
Virology
|
May 5, 2007
Functional homology of gHs and gLs from EBV-related gamma-herpesviruses for EBV-induced membrane fusion
Jasmina Omerović, Richard Longnecker
Molecular Cancer Therapeutics
|
February 2, 2011
Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma
Osman Cen, Richard Longnecker
Journal of Virology
|
October 13, 2006
Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity
Mark Rovedo, Richard Longnecker
Virology
|
December 8, 2006
Cholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stability
Masato Ikeda, Richard Longnecker
Journal of Virology
|
January 30, 2004
Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway
Makoto Fukuda, Richard Longnecker
Journal of Virology
|
June 27, 2008
Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn
Mark Rovedo, Richard Longnecker
Journal of Virology
|
December 13, 2002
Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development
Toni Portis, Richard Longnecker
Page
of 16